A Pivotal Technology in the Development of Gene Therapy: The ongoing CRISPR-Cas9 patent battle

Aaraf Dewan, M.Sc. Student Writer, Windsor Law LTEC Lab  J.D., 2019   On February 15,2017, the United States Patent and Trademark Office (USPTO decided to uphold the patents from both Feng Zhang and Jennifer Doudna regarding the CRISPR-Cas9 gene editing technology. The USPTO rejected Doudna’s claim that Zhang’s patents, had interfering claims with her earlier… Continue reading

More...